GSK and GE Healthcare Life Sciences, in partnership with Roche and CEPiA Sanofi, are pleased announce their fourth oligonucleotide networking event. The title of this year's event is "Bubbling-under Technologies" with the aim of highlighting new methods and technologies that have the potential for being first-line options for oligonucleotide research and manufacture in the future. The meeting is kindly being hosted by GSK at their facility in Stevenage.